OSL.AX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 14:10):

Stats
今日成交量	1.14M
平均成交量	3.26M
市值	14.81M
EPS	$0 ( 2024-02-25 )
下一个收益日期	( $0 ) 2024-05-15
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.400
ATR14	$0 (0.00%)

Oncosil Medical Ltd 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Oncosil Medical Ltd 财务报表

Annual	2023
营收:	$367 677
毛利润:	$-6.49M (-1 766.30 %)
EPS:	$-0.00950

FY	2023
营收:	$367 677
毛利润:	$-6.49M (-1 766.30 %)
EPS:	$-0.00950

FY	2022
营收:	$231 789
毛利润:	$-6.73M (-2 902.18 %)
EPS:	$-0.0102

FY	2021
营收:	$213 070
毛利润:	$-747 953 (-351.04 %)
EPS:	$-0.0159

Financial Reports:

No articles found.

Oncosil Medical Ltd

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.